---
title: "IOVA.US (IOVA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/IOVA.US/news.md"
symbol: "IOVA.US"
name: "IOVA.US"
parent: "https://longbridge.com/en/quote/IOVA.US.md"
datetime: "2026-05-20T22:50:24.790Z"
locales:
  - [en](https://longbridge.com/en/quote/IOVA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IOVA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IOVA.US/news.md)
---

# IOVA.US (IOVA.US) — Related News

### [Iovance’s Terminated TIL Study Reshapes Expectations for Solid-Tumor Growth](https://longbridge.com/en/news/286593782.md)
*2026-05-15T16:30:48.000Z*
> Iovance Biotherapeutics has terminated its Phase 2 trial of tumor-infiltrating lymphocyte therapy for solid tumors, whic

### [Iovance Biotherapeautics | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 71.43 M](https://longbridge.com/en/news/285560850.md)
*2026-05-07T13:19:56.000Z*
### [Top 10 US Stock Gainers (5.4)](https://longbridge.com/en/news/285128207.md)
*2026-05-04T22:01:01.000Z*
> Global Business Travel(GBTG) rose 57.5%, with a trading turnover 756.9 Million USD, and a year-to-date rose 22.1%. Circl

### [CM Management LLC Decreases Stock Holdings in Iovance Biotherapeutics, Inc. $IOVA](https://longbridge.com/en/news/284988720.md)
*2026-05-03T08:45:19.000Z*
> CM Management LLC has reduced its stake in Iovance Biotherapeutics, Inc. by 42.9%, now holding 400,000 shares after sell

### [Will FDA’s RP1 Setback Refocus Iovance Biotherapeutics' (IOVA) Post-Checkpoint Melanoma Narrative?](https://longbridge.com/en/news/283640022.md)
*2026-04-22T10:00:50.000Z*
> Iovance Biotherapeutics is seeing a potential boost in its competitive position following the FDA's setback for Replimun

### [Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | IOVA Stock News](https://longbridge.com/en/news/283196500.md)
*2026-04-17T13:15:51.000Z*
> Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | IOVA Stock News